Simplex Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200
Closed -$3.18K 9597
2026
Q1
$3.18K Sell
200
-11,300
-98% -$245K ﹤0.01% 8153
2025
Q4
$302K Buy
11,500
+11,300
+5,650% +$293K ﹤0.01% 3808
2025
Q3
$4K Sell
200
-300
-60% -$6.18K ﹤0.01% 8406
2025
Q2
$9K Buy
500
+200
+67% +$3.9K ﹤0.01% 7377
2025
Q1
$5K Buy
+300
New +$5.11K ﹤0.01% 7541
2024
Q4
Sell
-400
Closed -$8K 8856
2024
Q3
$8K Sell
400
-5,800
-94% -$130K ﹤0.01% 7317
2024
Q2
$121K Buy
6,200
+1,900
+44% +$39.7K ﹤0.01% 5174
2024
Q1
$93K Sell
4,300
-100
-2% -$2.48K ﹤0.01% 5661
2023
Q4
$127K Buy
4,400
+1,700
+63% +$45.5K ﹤0.01% 5131
2023
Q3
$72K Sell
2,700
-3,100
-53% -$106K ﹤0.01% 5438
2023
Q2
$214K Sell
5,800
-4,700
-45% -$164K ﹤0.01% 4227
2023
Q1
$327K Buy
10,500
+700
+7% +$22.5K ﹤0.01% 3734
2022
Q4
$291K Sell
9,800
-10,900
-53% -$390K ﹤0.01% 3777
2022
Q3
$789K Sell
20,700
-300
-1% -$15K ﹤0.01% 2930
2022
Q2
$1.15M Buy
21,000
+7,600
+57% +$418K ﹤0.01% 2468
2022
Q1
$836K Buy
13,400
+2,400
+22% +$158K ﹤0.01% 3128
2021
Q4
$1.11M Sell
11,000
-26,100
-70% -$2.29M ﹤0.01% 2729
2021
Q3
$3.24M Buy
37,100
+300
+0.8% +$27.3K ﹤0.01% 1593
2021
Q2
$3.39M Buy
36,800
+36,352
+8,114% +$2.9M ﹤0.01% 1551
2021
Q1
$4.33M Buy
448
+127
+40% +$13.1K 0.01% 937
2020
Q4
$1.67M Buy
321
+308
+2,369% +$12.9K ﹤0.01% 1959
2020
Q3
$52K Buy
+13
New +$407 ﹤0.01% 5565

Other funds holding FLGT

Simplex Trading's FLGT Position: Q2 2026 in Review

Simplex Trading opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 633 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #7472 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FLGT as recently as Q2 2025.

Simplex Trading first reported a position in FLGT in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.09M in Q4 2020. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Simplex Trading held 633 shares of Fulgent Genetics worth $13K as of Q2 2026.
  • Fulgent Genetics was a new Simplex Trading position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7472 holding.
  • Simplex Trading first reported a position in Fulgent Genetics in Q3 2020 and has held it in 14 quarters since.
  • Simplex Trading's Fulgent Genetics position peaked at $1.09M in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.